Compound ID | 331
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell wall synthesis inhibitor. Penicillin-binding protein 2a (PBP2a) inhibitor |
| Target Pathogen: | Active against multidrug resistant streptococci and staphylococci |
| Description: | Cephalosporin-type |
| Institute where first reported: | LG Life Sciences, South Korea |
| Year first mentioned: | 2002 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9872839 |
| Citations: |
|